Welcome to APhA's Education Library


Click links below for more information

  • Can be sorted by Newest or By Title . (The titles are listed alphabetically.)
  • Goals / objectives of the course can be seen by clicking on the title
  • Enroll and/or purchase the course by clicking on Enroll Now or Add To Cart
  • Once purchased. the course will be found under My Training
  • TIP: Use the search engine, or scroll down to bottom and select 50 per page .
If you have registered for the APhA program through one of our licensed partners which is hosting the APhA Program - that Organization's coordinator will provide you with an enrollment code to gain access to the required course materials. You can redeem your enrollment code at My Training

APhA's Education Library

Found 145
Sort by
Home Study
Member $29.00
Non-Member $49.00

New Drugs 2015

Speaker: Daniel A. Hussar, Ph.D., Remington Professor of Pharmacy, Philadelphia College of Pharmacy, University of the Sciences. This video was recorded at the APhA2016 Annual Meeting and Exposition.
new drugs drug information
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2016: Part 1

Featuring elbasvir and grazoprevir; brivaracetam; reslizumab; Ixekizumab; and patiromer sorbitex calcium.
Home Study
Member Free
Non-Member $25.00

Maxed Out on Metformin—Now What? Individualized Diabetes Management

Over the past few decades, the understanding of diabetes pathophysiology and the pharmacotherapy armamentarium have rapidly expanded. It is now widely accepted that diabetes is a complex, multi-organ, chronic disease that requires continuous medical and educational care.
Home Study
Member Free
Non-Member $129.00

Saving Lives with Naloxone: Opportunity or Obligation?

Pharmacists are well-positioned to help address the overdose epidemic through proper medication management, counseling patients and caregivers about overdose risk reduction, and providing naloxone rescue kits to the community.
clinical patient care and services pain management drug information
Home Study
Member Free
Non-Member $25.00

Provider Status: It’s Happening

Provider status activities that promote patient access to pharmacists’ patient care services are crucial to addressing these barriers and optimizing the pharmacist’s role in the health care system.
Home Study
Member $29.00
Non-Member $49.00

Smoothing the Path Home: Managing Transitions of Care for Patients with Acute Coronary Syndrome

Speakers: Karen J. McConnell, Pharm.D, FCCP, BCPS-AQ Cardiology, Clinical Director and Cardiology Subject Matter Expert, Cardinal Health; Paul P. Dobesh, Pharm.D, FCCP, BCPS-AQ Cardiology, Professor of Pharmacy Practice, University of Nebraska Medical Center, College of Pharmacy.
Home Study
Member $29.00
Non-Member $49.00

Rooting Out Errors in Your Pharmacy

Speaker: Donna Horn, RPh; DPhKaren Ryle MS., RPh. This video was recorded at the APhA2016 Annual Meeting and Exposition.
Home Study
Member $29.00
Non-Member $49.00

Provider Status: It's Happening

Speakers: Stacie Maass, RPh, JD, Senior Vice President, Pharmacy Practice and Government Affairs, American Pharmacists Association, Washington, D.C. This video was recorded at the APhA2016 Annual Meeting and Exposition.
Home Study
Member $29.00
Non-Member $49.00

Opening General Session: Pharmacists Improve Care Through Team Collaboration

Pharmacists have long known the value that they provide to patient care when they have opportunities to improve collaboration among health care team members.
Home Study
Member $29.00
Non-Member $49.00

Legislative and Regulatory Update 2015

Speakers: Michael Spira, Senior Lobbyist, Jillanne Schulte, JD, Director of Regulatory Affairs; Jenna Ventresca, JD, Assoc. Director of Health Policy, American Pharmacists Association, Washington, D.C. This video was recorded at the APhA2016 Annual Meeting and Exposition.
Home Study
Member $29.00
Non-Member $49.00

Immunization Update 2015

Speakers: Stephan L. Foster, Pharm.D, FAPhA, Professor, University of Tennessee; Jeff Goad, Pharm.D., M.P.H.,FAPhA, Professor and Chair, Chapman University. This video was recorded at the APhA2016 Annual Meeting and Exposition.
Home Study
Member $29.00
Non-Member $49.00

Diabetes Update 2016

Speakers: Staci Marie Norman, PharmD, CDE, Clinical Coordinator, Martin’s Pharmacy; Jennifer D. Smith, PharmD, CPP, BC-ADM, CDE, Associate Professor of Pharmacy Practice, Campbell University, Clinical Pharmacist Practitioner, Wilson Community Health Center.
Home Study
Member $29.00
Non-Member $49.00

Beware: Clinically Significant Drug Interactions in the Treatment of HIV

Speaker: Betty J. Dong, PharmD, FCCP, FASHP, FAPHA, AAHIVP, Professor of Clinical Pharmacy and Family and Community Medicine, University of California Schools of Pharmacy and Medicine, San Francisco. This video was recorded at the APhA2016 Annual Meeting and Exposition.
Home Study
Member Free
Non-Member N/A

Technician Roles in Community Pharmacy MTM and Medication Safety

This technician-specific activity will focus on the technician’s role in helping patients achieve positive therapeutic outcomes as a result of medication therapy management (MTM). Medication safety as it pertains to MTM will also be discussed.
clinical patient care and services
Home Study
Member Free
Non-Member $25.00

Managing Clinically Significant Drug Interactions in Patients with HIV and Comorbid Conditions

The objective of this activity is to review common drug interactions associated with the use of anti-retroviral (ARV) agents for treatment of HIV and comorbid conditions, and to provide pharmacists with guidance for managing potential interactions.
hiv drug interactions drug information
Home Study
Member Free
Non-Member $25.00

Hot Topics in Immunization

This review will describe recent changes in recommended immunization practices, including the introduction of new vaccines, and will explore other immunization issues of interest to pharmacists.
immunizations
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 4

In this review, eleven new therapeutic agents marketed in the United States in 2015 are considered: selexipag, cobimetinib, osimertinib, necitumumab, alectinib, insulin degludec, lesinurad, mepolizumab, brexpiprazole, cariprazine, and flibanserin.
new drugs drug information
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 3

This review covers 11 new therapeutic agents approved in the United States in 2015.
new drugs drug information
Home Study
Member Free
Non-Member $25.00

Expanding the Use of Naloxone to Treat Opioid Overdose

Pharmacists who are well informed about the use and regulatory framework for naloxone can help address barriers to naloxone access and reduce the public health burden of opioid overdose.
new drugs addiction pain management drug information
Home Study
Member Free
Non-Member $25.00

New Therapeutic Agents Marketed in 2015: Part 2

In this review, eight new therapeutic agents marketed in the United States in 2015 are considered: ivabradine, cangrelor, deoxycholic acid, filgrastim-sndz, cholic acid, eluxadoline, parathyroid hormone, and lumacaftor-ivacaftor.
clinical patient care and services new drugs